Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis
Clinical trial NCT01087788 · COMPLETED
Trial details
- NCT number
- NCT01087788
- Sponsor
- UCB BIOSCIENCES GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2011-11-01
- Enrollment
- 409
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.